nausea after eating on tirzepatide Your guide to GLP-1 side effects Medical weight loss can feel

[DOI] [PubMed] [Google Scholar] 64.Cai J, Chen Y, Seth S, Furukawa S, Compans RW, Jones DP

Jones, R., & Rhee, D

Store at 1530

The general rule for pen needles is the same as for syringes

Mounjaro (Tirzepatide) Dual action: targets both GLP-1 and GIP receptors Strong appetite suppression & improved blood sugar control Clinical trials show average body weight loss up to 22.5% over 72 weeks Wegovy (Semaglutide) Targets GLP-1 receptors only Licensed in the UK for obesity and cardiovascular protection STEP trials show 1521% body weight loss A new 7.2mg dose is expected in late 2025, with results potentially matching Mounjaro Both treatments are once-weekly injections, prescribed alongside healthy diet and lifestyle changes

-